CYP2C19 Loss‐of‐function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

CYP2C19 Loss‐of‐function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes

Published:2021-10-30 Issue:2 Volume:111 Page:461-469
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Wang Ke¹,Yang Aimin¹²,Shi Mai¹,Tam Claudia C. H.¹³,Lau Eric S. H.¹,Fan Baoqi¹³,Lim Cadmon K. P.¹³,Lee Heung Man¹³,Kong Alice P. S.¹³,Luk Andrea O. Y.¹²³⁴,Tomlinson Brian¹⁵,Ma Ronald C. W.¹²³,Chan Juliana C. N.¹²³⁴,Chow Elaine¹⁴^ORCID

Affiliation:

1. Department of Medicine and Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong SAR China

2. Hong Kong Institute of Diabetes and Obesity The Chinese University of Hong Kong Prince of Wales Hospital Shatin, Hong Kong SAR China

3. Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Prince of Wales Hospital Shatin, Hong Kong SAR China

4. Phase 1 Clinical Trial Centre The Chinese University of Hong Kong Prince of Wales Hospital Shatin, Hong Kong SAR China

5. Faculty of Medicine Macau University of Science and Technology Macau China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2446

Reference34 articles.

1. Do sulphonylureas still have a place in clinical practice?

2. Trends in Glucose-Lowering Drug Use, Glycemic Control, and Severe Hypoglycemia in Adults With Diabetes in Hong Kong, 2002–2016

3. Is gliclazide a sulfonylurea with difference? A review in 2016

4. The mode of action and clinical pharmacology of gliclazide: a review

5. Progression to treatment failure among Chinese patients with type 2 diabetes initiated on metformin versus sulphonylurea monotherapy—The Hong Kong Diabetes Registry

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

2. Real-world evidence on health-related quality of life in patients with type 2 diabetes mellitus using sulphonylureas: An analysis of the Joint Asia Diabetes Evaluation (JADE) Register;Diabetes Research and Clinical Practice;2023-09

3. Evaluating gliclazide for the treatment of type 2 diabetes mellitus;Expert Opinion on Pharmacotherapy;2022-11-10

4. Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation ( JADE ) register;Diabetes, Obesity and Metabolism;2022-09-26

5. Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673–2682;Diabetes Care;2022-03-29